loader

Dyne Therapeutics Inc.

NASDAQ:DYN
Featured Articles and Interviews
Press Releases

Dyne Therapeutics to Present at Jefferies Global Healthcare Conference

Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares

Dyne Therapeutics Announces Pricing of $325.5 Million Public Offering of Common Stock

Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy.

Interactive Chart

×